271 related articles for article (PubMed ID: 20345848)
1. The role of microRNAs in ovarian cancer initiation and progression.
Li SD; Zhang JR; Wang YQ; Wan XP
J Cell Mol Med; 2010 Sep; 14(9):2240-9. PubMed ID: 20345848
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of microRNA-196b Accelerates Invasiveness of Cancer Cells in Recurrent Epithelial Ovarian Cancer Through Regulation of Homeobox A9.
Chong GO; Jeon HS; Han HS; Son JW; Lee YH; Hong DG; Park HJ; Lee YS; Cho YL
Cancer Genomics Proteomics; 2017; 14(2):137-141. PubMed ID: 28387653
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA signatures in human ovarian cancer.
Iorio MV; Visone R; Di Leva G; Donati V; Petrocca F; Casalini P; Taccioli C; Volinia S; Liu CG; Alder H; Calin GA; Ménard S; Croce CM
Cancer Res; 2007 Sep; 67(18):8699-707. PubMed ID: 17875710
[TBL] [Abstract][Full Text] [Related]
4. miRNA-200a/c as potential biomarker in epithelial ovarian cancer (EOC): evidence based on miRNA meta-signature and clinical investigations.
Teng Y; Su X; Zhang X; Zhang Y; Li C; Niu W; Liu C; Qu K
Oncotarget; 2016 Dec; 7(49):81621-81633. PubMed ID: 27835595
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA Expression Profiling of Epithelial Ovarian Cancer Identifies New Markers of Tumor Subtype.
Rattanapan Y; Korkiatsakul V; Kongruang A; Siriboonpiputtana T; Rerkamnuaychoke B; Chareonsirisuthigul T
Microrna; 2020; 9(4):289-294. PubMed ID: 32703147
[TBL] [Abstract][Full Text] [Related]
6. Role of microRNAs in ovarian cancer pathogenesis and potential clinical implications.
Mezzanzanica D; Bagnoli M; De Cecco L; Valeri B; Canevari S
Int J Biochem Cell Biol; 2010 Aug; 42(8):1262-72. PubMed ID: 20035894
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of microRNA-630 inhibits cell proliferation and invasion and enhances chemosensitivity in human ovarian carcinoma.
Zou YT; Gao JY; Wang HL; Wang Y; Wang H; Li PL
Genet Mol Res; 2015 Jul; 14(3):8766-77. PubMed ID: 26345808
[TBL] [Abstract][Full Text] [Related]
8. Novel miRNA genes deregulated by aberrant methylation in ovarian carcinoma are involved in metastasis.
Loginov VI; Pronina IV; Burdennyy AM; Filippova EA; Kazubskaya TP; Kushlinsky DN; Utkin DO; Khodyrev DS; Kushlinskii NE; Dmitriev AA; Braga EA
Gene; 2018 Jul; 662():28-36. PubMed ID: 29631007
[TBL] [Abstract][Full Text] [Related]
9. Molecular pathogenesis and therapeutic targets in epithelial ovarian cancer.
Chien JR; Aletti G; Bell DA; Keeney GL; Shridhar V; Hartmann LC
J Cell Biochem; 2007 Dec; 102(5):1117-29. PubMed ID: 17879946
[TBL] [Abstract][Full Text] [Related]
10. miR-99a promotes proliferation targeting FGFR3 in human epithelial ovarian cancer cells.
Jiang H; Qu L; Wang Y; Cong J; Wang W; Yang X
Biomed Pharmacother; 2014 Mar; 68(2):163-9. PubMed ID: 24456664
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-137 suppresses tumor growth in epithelial ovarian cancer in vitro and in vivo.
Zhang L; Li Z; Gai F; Wang Y
Mol Med Rep; 2015 Aug; 12(2):3107-14. PubMed ID: 25955305
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs in ovarian carcinomas.
Dahiya N; Morin PJ
Endocr Relat Cancer; 2010 Mar; 17(1):F77-89. PubMed ID: 19903743
[TBL] [Abstract][Full Text] [Related]
13. miRNAs as prognostic and therapeutic tools in epithelial ovarian cancer.
Nagaraj AB; Joseph P; DiFeo A
Biomark Med; 2015; 9(3):241-57. PubMed ID: 25731210
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA‑455 inhibits cell proliferation and invasion of epithelial ovarian cancer by directly targeting Notch1.
Xu L; Li H; Su L; Lu Q; Liu Z
Mol Med Rep; 2017 Dec; 16(6):9777-9785. PubMed ID: 29039517
[TBL] [Abstract][Full Text] [Related]
15. Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells.
Yoshimura A; Sawada K; Nakamura K; Kinose Y; Nakatsuka E; Kobayashi M; Miyamoto M; Ishida K; Matsumoto Y; Kodama M; Hashimoto K; Mabuchi S; Kimura T
BMC Cancer; 2018 Nov; 18(1):1065. PubMed ID: 30396333
[TBL] [Abstract][Full Text] [Related]
16. The miR-200 Family: Versatile Players in Epithelial Ovarian Cancer.
Muralidhar GG; Barbolina MV
Int J Mol Sci; 2015 Jul; 16(8):16833-47. PubMed ID: 26213923
[TBL] [Abstract][Full Text] [Related]
17. miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6.
Xia B; Yang S; Liu T; Lou G
Mol Cancer; 2015 Mar; 14():57. PubMed ID: 25889927
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-130b functions as a tumor suppressor by regulating RUNX3 in epithelial ovarian cancer.
Paudel D; Zhou W; Ouyang Y; Dong S; Huang Q; Giri R; Wang J; Tong X
Gene; 2016 Jul; 586(1):48-55. PubMed ID: 27048832
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA RHPN1-AS1 promotes tumorigenesis and metastasis of ovarian cancer by acting as a ceRNA against miR-596 and upregulating LETM1.
Wang J; Ding W; Xu Y; Tao E; Mo M; Xu W; Cai X; Chen X; Yuan J; Wu X
Aging (Albany NY); 2020 Mar; 12(5):4558-4572. PubMed ID: 32163372
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of miR-1294 associates with prognosis and tumor progression in epithelial ovarian cancer.
Guo TY; Xu HY; Chen WJ; Wu MX; Dai X
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7646-7652. PubMed ID: 30536306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]